Advances in the treatment of non-small cell lung cancer.

Advances in the treatment of non-small cell lung cancer. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Advances in the treatment of non-small cell lung cancer. Abstract Text:

While there have been advances in the treatment of lung cancer, they have been marginal in comparison with recent advances in the chemotherapy and molecularly targeted treatment of breast cancer, colorectal cancer and genitourinary cancer. Lung cancer is an extremely difficult disease to treat, and to obtain positive results and to develop new standard treatment. The results of clinical trial on gefitinib and erlotinib suggest that the evaluation of molecular target drugs seems to be quite difficult in unselected patient population and may be different from cytotoxic drugs. We need to find out specific molecular biomarkers for each drug. With global studies in view, it will be essential to obtain even more significant results by sophisticated clinical trials in selected patient populations and contribute to improving the treatment outcome of lung cancer patients.

Advances in the treatment of non-small cell lung cancer. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Advances in the treatment of non-small cell lung cancer. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Cancer treatment reviews

VOLUME: 34

Page Numbers: 521-6

Journal Abbreviation: Cancer Treat. Rev.

ISSN: 0305-7372

DAY: 22

MONTH: 05

YEAR: 2008

Advances in the treatment of non-small cell lung cancer. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7502030

Advances in the treatment of non-small cell lung cancer. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Advances in the treatment of non-small cell lung cancer. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Advances in the treatment of non-small cell lung cancer.

AFFILIATION: National Cancer Center, Hospital East, Kashiwanoha 6-5-1, Kashiwa-shi, Chiba 277-8577, Japan.

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Cancer Treat Rev

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Advances in the treatment of non-small cell lung cancer Related Publications

• A literature review of molecular markers predictive of clinical response to cytotoxic chemotherapy in patients with lung cancer.
• Advances in the treatment of non-small cell lung cancer.
• Blood Flow Visualization of Left Atrial Spontaneous Echo Contrast (SEC) Using gradient based optical flow estimation.
• Immunology: Oxysterols hold T cells in check.
• Phase II trial of preoperative chemoradiotherapy followed by surgical resection in patients with superior sulcus non-small-cell lung cancers: report of Japan Clinical Oncology Group trial 9806.
• Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer: JCOG 9702.
• Randomized phase II trial of three intrapleural therapy regimens for the management of malignant pleural effusion in previously untreated non-small cell lung cancer: JCOG 9515.
• Suppression of surfactant protein A by an epidermal growth factor receptor tyrosine kinase inhibitor exacerbates lung inflammation.
• Weekly epoetin beta maintains haemoglobin levels and improves quality of life in patients with non-myeloid malignancies receiving chemotherapy.